Nanoparticle-based Bioactive Agent Release Systems for Bone and Cartilage Tissue Engineering

Overview

Journal Regen Ther

Date 2019 Jun 28

PMID 31245450

Citations 13

Authors

Nelson Monteiro

Albino Martins

Rui L Reis

Nuno M Neves

Affiliations

Soon will be listed here.

Abstract

The inability to deliver bioactive agents locally in a transient but sustained manner is one of the challenges on the development of bio-functionalized scaffolds for tissue engineering (TE) and regenerative medicine. The mode of release is especially relevant when the bioactive agent is a growth factor (GF), because the dose and the spatiotemporal release of such agents at the site of injury are crucial to achieve a successful outcome. Strategies that combine scaffolds and drug delivery systems have the potential to provide more effective tissue regeneration relative to current therapies. Nanoparticles (NPs) can protect the bioactive agents, control its profile, decrease the occurrence and severity of side effects and deliver the bioactive agent to the target cells maximizing its effect. Scaffolds containing NPs loaded with bioactive agents can be used for their local delivery, enabling site-specific pharmacological effects such as the induction of cell proliferation and differentiation, and, consequently, neo-tissue formation. This review aims to describe the concept of combining NPs with scaffolds, and the current efforts aiming to develop highly multi-functional bioactive agent release systems, with the emphasis on their application in TE of connective tissues.

Citing Articles

Enhancing Bioactivity of Titanium-Based Materials Through Chitosan Based Coating and Calcitriol Functionalization.

Doymus B, Pekozer G, Onder S Ann Biomed Eng. 2025; .

PMID: 39871063 DOI: 10.1007/s10439-025-03684-4.

Advancements in fertility preservation strategies for pediatric male cancer patients: a review of cryopreservation and transplantation of immature testicular tissue.

Sung Z, Liao Y, Hou J, Lai H, Weng S, Jao H Reprod Biol Endocrinol. 2024; 22(1):47.

PMID: 38637872 PMC: 11025181. DOI: 10.1186/s12958-024-01219-5.

Nanoparticle Synthesis and Their Integration into Polymer-Based Fibers for Biomedical Applications.

Domingues J, Miranda C, Homem N, Felgueiras H, Antunes J Biomedicines. 2023; 11(7).

PMID: 37509502 PMC: 10377033. DOI: 10.3390/biomedicines11071862.

Human SMILE-Derived Stromal Lenticule Scaffold for Regenerative Therapy: Review and Perspectives.

Santra M, Liu Y, Jhanji V, Yam G Int J Mol Sci. 2022; 23(14).

PMID: 35887309 PMC: 9315730. DOI: 10.3390/ijms23147967.

Triamcinolone acetonide-loaded nanoparticles encapsulated by CD90 MCSs-derived microvesicles drive anti-inflammatory properties and promote cartilage regeneration after osteoarthritis.

Li Y, Tu Q, Xie D, Chen S, Gao K, Xu X J Nanobiotechnology. 2022; 20(1):150.

PMID: 35305656 PMC: 8934450. DOI: 10.1186/s12951-022-01367-z.

References

Chung H, Park T . Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev. 2007; 59(4-5):249-62. DOI: 10.1016/j.addr.2007.03.015. View

Fischer H, Chan W . Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol. 2007; 18(6):565-71. DOI: 10.1016/j.copbio.2007.11.008. View

Kulkarni M, Breen A, Greiser U, OBrien T, Pandit A . Fibrin-lipoplex system for controlled topical delivery of multiple genes. Biomacromolecules. 2009; 10(6):1650-4. DOI: 10.1021/bm900248n. View

Oliveira J, Sousa R, Kotobuki N, Tadokoro M, Hirose M, Mano J . The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials. 2008; 30(5):804-13. DOI: 10.1016/j.biomaterials.2008.10.024. View

Park K, Kim H, Moon S, Na K . Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J Biosci Bioeng. 2009; 108(6):530-7. DOI: 10.1016/j.jbiosc.2009.05.021. View

Yamauchi F, Kato K, Iwata H . Layer-by-layer assembly of poly(ethyleneimine) and plasmid DNA onto transparent indium-tin oxide electrodes for temporally and spatially specific gene transfer. Langmuir. 2005; 21(18):8360-7. DOI: 10.1021/la0505059. View

Chung B, Kang L, Khademhosseini A . Micro- and nanoscale technologies for tissue engineering and drug discovery applications. Expert Opin Drug Discov. 2013; 2(12):1653-68. DOI: 10.1517/17460441.2.12.1653. View

Curran J, Chen R, Hunt J . The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials. 2006; 27(27):4783-93. DOI: 10.1016/j.biomaterials.2006.05.001. View

Meyenburg S, Lilie H, Panzner S, Rudolph R . Fibrin encapsulated liposomes as protein delivery system. Studies on the in vitro release behavior. J Control Release. 2000; 69(1):159-68. DOI: 10.1016/s0168-3659(00)00295-9. View

10.

Hillaireau H, Couvreur P . Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009; 66(17):2873-96. PMC: 11115599. DOI: 10.1007/s00018-009-0053-z. View

11.

Bengali Z, Shea L . Gene Delivery by Immobilization to Cell-Adhesive Substrates. MRS Bull. 2009; 30(9):659-662. PMC: 2659659. DOI: 10.1557/mrs2005.193. View

12.

Zhang S, Kucharski C, Doschak M, Sebald W, Uludag H . Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials. 2009; 31(5):952-63. DOI: 10.1016/j.biomaterials.2009.10.011. View

13.

Bessa P, Machado R, Nurnberger S, Dopler D, Banerjee A, Cunha A . Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J Control Release. 2009; 142(3):312-8. DOI: 10.1016/j.jconrel.2009.11.003. View

14.

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

15.

Zhang J, Wu L, Chan H, Watanabe W . Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev. 2010; 63(6):441-55. DOI: 10.1016/j.addr.2010.11.002. View

16.

Jung Y, Chung Y, Kim S, Tae G, Kim Y, Rhie J . In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex. Biomaterials. 2009; 30(27):4657-64. DOI: 10.1016/j.biomaterials.2009.05.034. View

17.

Mickova A, Buzgo M, Benada O, Rampichova M, Fisar Z, Filova E . Core/shell nanofibers with embedded liposomes as a drug delivery system. Biomacromolecules. 2012; 13(4):952-62. DOI: 10.1021/bm2018118. View

18.

Ma P . Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2007; 60(2):184-98. PMC: 2271038. DOI: 10.1016/j.addr.2007.08.041. View

19.

Houchin-Ray T, Huang A, West E, Zelivyanskaya M, Shea L . Spatially patterned gene expression for guided neurite extension. J Neurosci Res. 2008; 87(4):844-56. PMC: 2764322. DOI: 10.1002/jnr.21908. View

20.

Kulkarni M, Greiser U, OBrien T, Pandit A . Liposomal gene delivery mediated by tissue-engineered scaffolds. Trends Biotechnol. 2009; 28(1):28-36. DOI: 10.1016/j.tibtech.2009.10.003. View